These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 34944829)

  • 1. The Role of Breast Cancer Stem Cells in Chemoresistance and Metastasis in Triple-Negative Breast Cancer.
    He L; Wick N; Germans SK; Peng Y
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulated SCUBE2 expression in breast cancer stem cells enhances triple negative breast cancer aggression through modulation of notch signaling and epithelial-to-mesenchymal transition.
    Chen JH; Kuo KT; Bamodu OA; Lin YC; Yang RB; Yeh CT; Chao TY
    Exp Cell Res; 2018 Sep; 370(2):444-453. PubMed ID: 29981340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer.
    Lin CC; Lo MC; Moody R; Jiang H; Harouaka R; Stevers N; Tinsley S; Gasparyan M; Wicha M; Sun D
    Cancer Lett; 2018 Dec; 438():165-173. PubMed ID: 30227220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An insight into the cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer.
    Qayoom H; Wani NA; Alshehri B; Mir MA
    Future Oncol; 2021 Nov; 17(31):4185-4206. PubMed ID: 34342489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT3 as a promising chemoresistance biomarker associated with the CD44
    Moreira MP; da Conceição Braga L; Cassali GD; Silva LM
    Exp Cell Res; 2018 Feb; 363(2):283-290. PubMed ID: 29352988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of the Eukaryotic Translation Initiation Factor 4A Against Breast Cancer Stemness.
    Sridharan S; Robeson M; Bastihalli-Tukaramrao D; Howard CM; Subramaniyan B; Tilley AMC; Tiwari AK; Raman D
    Front Oncol; 2019; 9():1311. PubMed ID: 31867270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cell-derived CHI3L1 activates the MAF/CTLA4 signaling pathway to promote immune escape in triple-negative breast cancer.
    Ji S; Yu H; Zhou D; Fan X; Duan Y; Tan Y; Lang M; Shao G
    J Transl Med; 2023 Oct; 21(1):721. PubMed ID: 37838657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of NuMA1 in breast cancer stem cells with implications for combination therapy of PIM1 and autophagy inhibition in triple negative breast cancer.
    Manupati K; Hao M; Haas M; Yeo SK; Guan JL
    Res Sq; 2024 Apr; ():. PubMed ID: 38645153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance.
    Saha T; Lukong KE
    Front Oncol; 2022; 12():856974. PubMed ID: 35392236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the interplay between triple-negative breast cancer stem cells and tumor microenvironment for effective therapeutic strategies.
    Zou Z; Luo T; Wang X; Wang B; Li Q
    J Cell Physiol; 2024 Aug; 239(8):e31278. PubMed ID: 38807378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ganglioside GD2: a novel therapeutic target in triple-negative breast cancer.
    Shao C; Anand V; Andreeff M; Battula VL
    Ann N Y Acad Sci; 2022 Feb; 1508(1):35-53. PubMed ID: 34596246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting triple negative breast cancer stem cells using nanocarriers.
    Dasari N; Guntuku GS; Pindiprolu SKSS
    Discov Nano; 2024 Mar; 19(1):41. PubMed ID: 38453756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Cancer Stem Cells in Triple-Negative Breast Cancer.
    Park SY; Choi JH; Nam JS
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31324052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of tRNA-derived small noncoding RNAs as potential biomarkers for prediction of recurrence in triple-negative breast cancer.
    Feng W; Li Y; Chu J; Li J; Zhang Y; Ding X; Fu Z; Li W; Huang X; Yin Y
    Cancer Med; 2018 Oct; 7(10):5130-5144. PubMed ID: 30239174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel and Alternative Targets Against Breast Cancer Stemness to Combat Chemoresistance.
    Sridharan S; Howard CM; Tilley AMC; Subramaniyan B; Tiwari AK; Ruch RJ; Raman D
    Front Oncol; 2019; 9():1003. PubMed ID: 31681564
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Rios-Fuller TJ; Ortiz-Soto G; Lacourt-Ventura M; Maldonado-Martinez G; Cubano LA; Schneider RJ; Martinez-Montemayor MM
    Oncotarget; 2018 Nov; 9(89):35907-35921. PubMed ID: 30542507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Triple Negative Breast Cancer Stem Cells by Heat Shock Protein 70 Inhibitors.
    Tsai CH; Weng JR; Lin HW; Lu MT; Liu YC; Chu PC
    Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZGRF1 Is Associated with Poor Prognosis in Triple-Negative Breast Cancer and Promotes Cancer Stemness Based on Bioinformatics.
    Ge W; Jiang M; Zhang F; Ma Y; Wang H; Xu Y
    Onco Targets Ther; 2020; 13():2843-2854. PubMed ID: 32308418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stem cells in triple-negative breast cancer: a potential target and prognostic marker.
    O'Conor CJ; Chen T; González I; Cao D; Peng Y
    Biomark Med; 2018 Jul; 12(7):813-820. PubMed ID: 29902924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOTCH4 maintains quiescent mesenchymal-like breast cancer stem cells via transcriptionally activating SLUG and GAS1 in triple-negative breast cancer.
    Zhou L; Wang D; Sheng D; Xu J; Chen W; Qin Y; Du R; Yang X; He X; Xie N; Liu S; Zhang L
    Theranostics; 2020; 10(5):2405-2421. PubMed ID: 32104513
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.